- Email: [email protected]
NCCLS News
NCCLS News ard; M7-A3, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Third Edition; Approved Standard; and M11A3, Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria-Third Edition; Approved Standard. The standards contain information about both disk (M2) and dilution (M7) test procedures for aerobic bacteria and five different dilution methodologies for anaerobic bacteria (M11). Clinicians depend heavily on information from the clinical microbiology laboratory for treatment of their seriously ill patients. The clinical impor-
tance of antimicrobial susceptibility test results requires that these tests be done under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. M100-S6 costs $25 for member organizations and $85 for nonmembers. Shipping and handling are $7.50 and $8.50, respectively. Payment is accepted by check, VISA, Mastercard, or purchase order. Discounts are available for multicopy purchases. For further information contact NCCLS at (610) 688-0100.
If your laboratory has isolated an uncommon organism from an unusual patient site, or an organism that presented a particular diagnostic challenge,why not share the information with your colleagues through the Clinical Microbiology Newsletter. The editors would like to receive interesting case reports from our
readers for possible publication in the Newsletter. Submitted case reports should contain: i) a brief clinical history summarizing the symptoms and course of illness; ii) a description of how the organism(s) were cultured and differentiated from closely associated organisms; and iii) the results of susceptibility tests for the iso-
late(+ Send the original typescript, four copies, and a diskette to:
Editors
General Information
NCCLS Announces Performance Standards for Antimicrobial Susceptibility Testing Wayne, PA-February 27,1996
NCCLS announces a new informational supplement, Performance Standards for Antimicrobial Susceptibility Testing (M100-S6). The infomation presented in this supplement is intended for use with the antimicrobial susceptibility testing procedures published in the following NCCLS approved standard: M2-A5, Performance Standards for Antimicrobial Disk Susceptibility Tests-Fifth Edition; Approved Stand-
Wanted-Case Reports
Mary Jane Ferraro Paul A. Granato Josephine A. Morello R.J. Zabransky
Marci Tlusty Clinical Microbiology Newsletter Elsevier Science Inc. 655 Avenue of the Americas New York, NY 10010
Subscription information can be found inside the front cover. This newsletter has been registered with the Copyright Clearance Center, Inc. Consent is given for copying articles for personal or internal use, or for the personal or internal use of specific clients. This consent is given on the condition that the copier pay through the Center the per-copy fee stated in the code on the first page for copying beyond that permitted by the US Copy right Law. If no code appears on an article, the author has not given broad consent to copy and permission to copy must be obtaineddirectly from the author. This consent does not extend to other kinds of copying, such as for general distribution, resale, advettising and promotional purposes, or for creating new collective works.
Q 1996 Elsevier Science Inc.
ISSN 0196-4399 CMNEEJ 18(10) 7340,1996
Address orders, changes of address, and claims for missing issues to Journal Fulfillment Department. Elsevier Science Inc., 655 Avenue of the Americas, New York. NY 10010. Claims for missing issues can be honored only up to three months for domestic addresses and six months for foreign addresses. Duplicate copies will not be sent to replace ones undelivered due to failure to notify Elsevier of change of address.
Elsevier
Postmaster: Send address changes to Clinical Microbiology Newsletter, Elsevier Science Inc.. 655 Avenue of the Americas, New York. NY 10010.
01%-4399(19960515)18:10;1-T
80
Ill[
0196-4399,96/S0.00 + 15.00
Editorials and letters printed in this newsletter are published forthe interest of the readers anddonotnecessarily reflect the opinions of the editors. Clinical Microbiology Newsletter is abstracted in Tropical Diseases Bulletin, Abstracts on Hygiene and Communicable Diseases and Current A I D S Literature.
Q 19% Elsevier Science Inc.
Clinical Microbiology Newsletter 18:10.1996
tance of antimicrobial susceptibility test results requires that these tests be done under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. M100-S6 costs $25 for member organizations and $85 for nonmembers. Shipping and handling are $7.50 and $8.50, respectively. Payment is accepted by check, VISA, Mastercard, or purchase order. Discounts are available for multicopy purchases. For further information contact NCCLS at (610) 688-0100.
If your laboratory has isolated an uncommon organism from an unusual patient site, or an organism that presented a particular diagnostic challenge,why not share the information with your colleagues through the Clinical Microbiology Newsletter. The editors would like to receive interesting case reports from our
readers for possible publication in the Newsletter. Submitted case reports should contain: i) a brief clinical history summarizing the symptoms and course of illness; ii) a description of how the organism(s) were cultured and differentiated from closely associated organisms; and iii) the results of susceptibility tests for the iso-
late(+ Send the original typescript, four copies, and a diskette to:
Editors
General Information
NCCLS Announces Performance Standards for Antimicrobial Susceptibility Testing Wayne, PA-February 27,1996
NCCLS announces a new informational supplement, Performance Standards for Antimicrobial Susceptibility Testing (M100-S6). The infomation presented in this supplement is intended for use with the antimicrobial susceptibility testing procedures published in the following NCCLS approved standard: M2-A5, Performance Standards for Antimicrobial Disk Susceptibility Tests-Fifth Edition; Approved Stand-
Wanted-Case Reports
Mary Jane Ferraro Paul A. Granato Josephine A. Morello R.J. Zabransky
Marci Tlusty Clinical Microbiology Newsletter Elsevier Science Inc. 655 Avenue of the Americas New York, NY 10010
Subscription information can be found inside the front cover. This newsletter has been registered with the Copyright Clearance Center, Inc. Consent is given for copying articles for personal or internal use, or for the personal or internal use of specific clients. This consent is given on the condition that the copier pay through the Center the per-copy fee stated in the code on the first page for copying beyond that permitted by the US Copy right Law. If no code appears on an article, the author has not given broad consent to copy and permission to copy must be obtaineddirectly from the author. This consent does not extend to other kinds of copying, such as for general distribution, resale, advettising and promotional purposes, or for creating new collective works.
Q 1996 Elsevier Science Inc.
ISSN 0196-4399 CMNEEJ 18(10) 7340,1996
Address orders, changes of address, and claims for missing issues to Journal Fulfillment Department. Elsevier Science Inc., 655 Avenue of the Americas, New York. NY 10010. Claims for missing issues can be honored only up to three months for domestic addresses and six months for foreign addresses. Duplicate copies will not be sent to replace ones undelivered due to failure to notify Elsevier of change of address.
Elsevier
Postmaster: Send address changes to Clinical Microbiology Newsletter, Elsevier Science Inc.. 655 Avenue of the Americas, New York. NY 10010.
01%-4399(19960515)18:10;1-T
80
Ill[
0196-4399,96/S0.00 + 15.00
Editorials and letters printed in this newsletter are published forthe interest of the readers anddonotnecessarily reflect the opinions of the editors. Clinical Microbiology Newsletter is abstracted in Tropical Diseases Bulletin, Abstracts on Hygiene and Communicable Diseases and Current A I D S Literature.
Q 19% Elsevier Science Inc.
Clinical Microbiology Newsletter 18:10.1996